カテゴリ： MarketLine, イギリス, 企業調査

Vectura Group plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Vectura Group plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1951
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Vectura Group plc – Strategy, SWOT and Corporate Finance Report
Summary

Vectura Group plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vectura Group plc (Vectura or ‘the group’) is engaged in the development of pharmaceutical therapies for the treatment of airways-related diseases. It develops inhalation products to diseases such as obstructive pulmonary disease (COPD), cystic fibrosis, asthma, chronic pulmonary fibrosis and other diseases. It offers dry powder inhalers (DPIs), pressurized metered dose inhaler (pMDI) and smart nebulizer delivery systems. The group’s portfolio is comprised of partnered and licensed marketed products as well as branded and generic investigational drugs. The group operates in the US, the UK and other European countries. It is headquartered in Wiltshire, UK.

Scope

- Detailed information on Vectura Group plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vectura Group plc in the form of a SWOT analysis
- An in-depth view of the business model of Vectura Group plc including a breakdown and examination of key business segments
- Intelligence on Vectura Group plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vectura Group plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vectura Group plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vectura Group plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vectura Group plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vectura Group plc: Company Overview 9
Vectura Group plc: Overview and Key Facts 9
Vectura Group plc: Overview 9
Vectura Group plc: Key Facts 9
Vectura Group plc: Key Employees 10
Vectura Group plc: Key Employee Biographies 11
Vectura Group plc: Major Products and Services 15
Vectura Group plc: Company History 17
Vectura Group plc: Management Statement 21
Vectura Group plc: Locations and Subsidiaries 24
Vectura Group plc: Key Competitors 25
Vectura Group plc: Company Analysis 26
Vectura Group plc: Business Description 26
Vectura Group plc: SWOT Analysis 27
Vectura Group plc: SWOT Overview 27
Vectura Group plc: Strengths 27
Vectura Group plc: Weaknesses 28
Vectura Group plc: Opportunities 28
Vectura Group plc: Threats 29
Vectura Group plc: Corporate Financial Deals Activity 30
Vectura Group plc: Financial Deals Overview 30
Vectura Group plc: Targets and Partners 32
Vectura Group plc: Top Deals 2014 – 2018YTD* 33
Vectura Group plc: Advisors 34
Vectura Group plc: Top Legal Advisors 34
Vectura Group plc: Top Financial Advisors 34
Vectura Group plc: Mergers and Acquisitions 35
Vectura Group plc: Capital Raising 36
Vectura Group plc: Partnership 37
Vectura Group plc: Recent Developments 38
Vectura Group plc: News and Events Summary 38
Vectura Group plc: Business Expansion 41
Vectura Group plc: Corporate Governance 41
Vectura Group plc: Financial Deals 42
Vectura Group plc: Financial Performance 42
Vectura Group plc: Market Developments 43
Vectura Group plc: Research & Development 44
Vectura Group plc: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Vectura Group plc: Key Facts
Table 2: Vectura Group plc: Key Employees
Table 3: Vectura Group plc: Locations and Subsidiaries
Table 4: Vectura Group plc: Key Competitors
Table 5: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Table 8: Vectura Group plc: Targets and Partners
Table 9: Vectura Group plc: Top Deals 2014 - 2018YTD*
Table 10: Vectura Group plc: Legal Advisor Ranking by Value (US$m)
Table 11: Vectura Group plc: Financial Advisor Ranking by Value (US$m)
Table 12: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Vectura Group plc: News and Events Summary
Table 19: Vectura Group plc: Business Expansion
Table 20: Vectura Group plc: Corporate Governance
Table 21: Vectura Group plc: Financial Deals
Table 22: Vectura Group plc: Financial Performance
Table 23: Vectura Group plc: Market Developments
Table 24: Vectura Group plc: Research & Development
Table 25: Vectura Group plc: Strategy and Operations

List of Figures
Figure 1: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Figure 4: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vectura Group plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • RentPath LLC：企業の戦略的SWOT分析
    RentPath LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Enterprise Products Partners LP (EPD)-石油・ガス分野：企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Integra LifeSciences Holdings Corp (IART)：企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Cemex SAB de CV (CEMEXCPO)：企業の財務・戦略的SWOT分析
    Cemex SAB de CV (CEMEXCPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bajaj Electricals Ltd. (BAJAJELEC)：企業の財務・戦略的SWOT分析
    Bajaj Electricals Ltd. (BAJAJELEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Allianz Group：企業のM&A・事業提携・投資動向
    Allianz Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allianz Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • CMS Energy Corp (CMS)：企業の財務・戦略的SWOT分析
    CMS Energy Corp (CMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Audi AG (NSU)：企業の財務・戦略的SWOT分析
    Audi AG (NSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Chimei Innolux Corporation (3481)：企業の財務・戦略的SWOT分析
    Chimei Innolux Corporation (3481) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • PartnerRe Ltd.：企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Net Insight AB (NETI B)：企業の財務・戦略的SWOT分析
    Net Insight AB (NETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Custodian & Allied Plc：企業の戦略・SWOT・財務分析
    Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report Summary Custodian & Allied Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Emerald Resources NL (EMR)：企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • PPL Corp (PPL)：石油・ガス：M&Aディール及び事業提携情報
    Summary PPL Corp (PPL) is an energy holding company. Through its subsidiaries, LG&E, Kentucky Utilities, and KU Energy, it generates, transmits, distributes, and sells electricity; and distributes and sells natural gas. The company produces electricity from coal, natural gas, oil, hydro, and solar s …
  • Lava Therapeutics BV：製薬・医療：M&Aディール及び事業提携情報
    Summary Lava Therapeutics BV (Lava Therapeutics) is a biotechnology company which develops immune oncology biopharmaceuticals products. Its proprietary V?9Vd2 T-cell engager candidates bind to the conserved (monomorphic) T-cell receptor of V?9Vd2 T-cells which exhibit potent cytotoxicity, interferon …
  • Samsung Securities Co., Ltd. (016360)：企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Neurimmune Holding AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Neurimmune Holding AG (Neurimmune), formerly Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics for human diseases. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human neurodeg …
  • China State Shipbuilding Corp：企業の戦略・SWOT・財務情報
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Brooks MacDonald Group PLC (BRK)：企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Virgin Group Ltd.：企業のM&A・事業提携・投資動向
    Virgin Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆